Gemstone Biotherapeutics Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $250K
Latest Deal Amount
  • Investors
  • 9

Gemstone Biotherapeutics General Information

Description

Developer of scar-free skin regeneration technology designed to address unmet medical needs in dermatology, plastic surgery and burn care. The company's technology offer products that accelerate healing, avoid complex closure and regenerate skin without scarring after burns or excisions, enabling patients to heal wounds.

Contact Information

Formerly Known As
Chiron Labs, Hydro3Labs, Gemstone Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 180 West Ostend Street
  • Suite 277A
  • Baltimore, MD 21230
  • United States
+1 (443) 000-0000

Gemstone Biotherapeutics Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Gemstone Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 28-Aug-2019 $250K 00.00 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2019 00.000 Completed Generating Revenue
4. Grant 22-Jun-2018 00000 00.000 Completed Generating Revenue
3. Early Stage VC 27-Oct-2016 00000 00.000 Completed Generating Revenue
2. Early Stage VC 08-Jun-2015 $1.6M $2.45M Completed Generating Revenue
1. Accelerator/Incubator 05-Feb-2015 $850K $850K Completed Generating Revenue
To view Gemstone Biotherapeutics’s complete valuation and funding history, request access »

Gemstone Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of scar-free skin regeneration technology designed to address unmet medical needs in dermatology, plastic surg
Drug Discovery
Baltimore, MD
4 As of 2020
00.00
0000000000 0 00.00

00000000

quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure
0000 000000000
Mont-Saint-Guibert, Belgium
00 As of 0000
00000
0000000000 0

00000 00

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostru
0000 000000000
Madison, WI
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gemstone Biotherapeutics Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Promethera Biosciences Venture Capital-Backed Mont-Saint-Guibert, Belgium 00 00000 0000000000 0
00000 00000000000 Venture Capital-Backed Madison, WI 00 000.00 0000000000 0 000.00
00000000 0000 0000 Corporation Vancouver, Canada 0 00.000 000000000 00.000
000000 0000 Formerly VC-backed Jerusalem, Israel 000 00000 00000000 00000
00000000 Private Equity-Backed Birkerød, Denmark 00 0000 0000000 0000 0000
You’re viewing 5 of 11 competitors. Get the full list »

Gemstone Biotherapeutics Patents

Gemstone Biotherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210069375-A1 Extracellular matrices, uses thereof, and method for making extracellular matrices Pending 28-Dec-2017 000000000

Gemstone Biotherapeutics Executive Team (4)

Name Title Board Seat Contact Info
Eric Clarke Chief Financial Officer
Sharon Gerecht Ph.D Co-Founder
You’re viewing 2 of 4 executive team members. Get the full list »

Gemstone Biotherapeutics Board Members (3)

Name Representing Role Since
David Oros Gemstone Biotherapeutics Board Member 000 0000
Geoff MacKay Gemstone Biotherapeutics Board Member 000 0000
Xin Huang Gemstone Biotherapeutics Board Member 000 0000
To view Gemstone Biotherapeutics’s complete board members history, request access »

Gemstone Biotherapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gemstone Biotherapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
The University System of Maryland Momentum Fund Venture Capital Minority 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator 000 0000 000000 0
Maryland Stem Cell Research Fund Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »